Subgroup analysis in RAISE: A randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression

  1. Obermannová, R.
  2. Van Cutsem, E.
  3. Yoshino, T.
  4. Bodoky, G.
  5. Prausová, J.
  6. Garcia-Carbonero, R.
  7. Ciuleanu, T.
  8. Garcia Alfonso, P.
  9. Portnoy, D.
  10. Cohn, A.
  11. Yamazaki, K.
  12. Clingan, P.
  13. Lonardi, S.
  14. Kim, T.W.
  15. Yang, L.
  16. Nasroulah, F.
  17. Tabernero, J.
Revue:
Annals of Oncology

ISSN: 1569-8041 0923-7534

Année de publication: 2016

Volumen: 27

Número: 11

Pages: 2082-2089

Type: Article

DOI: 10.1093/ANNONC/MDW402 GOOGLE SCHOLAR

Objectifs de Développement Durable